Central Kentucky Research is currently enrolling Migraine Sufferers in a Clinical Drug Study; The purpose of this study is to evaluate the effectiveness of an investigational medication – lasmiditan – at 50 mg, 100 mg, and 200 mg compared to a placebo at 2 hours on migraine headache pain. For more information about thus study please follow this link ------> http://www.ckraresearch.com/migraine-headaches-2/
In 2010, the U.S. Food and Drug Administration (FDA) approved the use of Botox, or onabotulinumtoxinA, for the treatment of chronic migraine, a serious medical condition that affects an estimated 3.2 million Americans. Dr. Raina Gupta, neurologist at Advocate Illinois Masonic Medical Center in Chicago, shares five things you should know about Botox treatment of migraine.
Headaches can be annoying. Migraine headaches can bring your entire day to a stop. Luckily, Botox injections can help reduce future headaches for chronic migraine sufferers! View this Frederick family dentist’s infographic for more facts.